Clinical trial Recruiting at 1 site Interventional Ages Any age to 50

Effects of a Ketogenic Diet on Seizures in Children

Official title: Precision Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

Run by University of Florida · NCT02216500 · Data updated 2026-11-12

This study tests if a ketogenic diet can help children with seizures who don't respond well to regular treatments by looking at how it affects their seizure frequency and medication needs.

More Seizures trials

Quick facts

Study typeInterventional
AgesAny age to 50 Years
SexAll
Enrollment400 (estimated)
SponsorUniversity of Florida
Academic / other
Locations1 site (Gainesville, Florida)
StatusRecruiting
StartedSeptember 2006
Main results expectedOctober 2030
Study endsOctober 2031
Registry record updatedSeptember 17, 2026
Trial IDNCT02216500 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children whose physicians have prescribed the ketogenic diet and who can metabolize a high-fat, low-carbohydrate diet.

Probably not a fit

Patients with metabolic issues that prevent them from safely following a high-fat diet may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of ketogenic therapy on children with seizures who do not respond adequately to standard treatments. It focuses on understanding how the ketogenic diet, which alters macronutrient intake to favor fats over carbohydrates, impacts seizure frequency and the need for antiepileptic medications. The study will also assess potential adverse effects, such as dyslipidemia and growth issues, while providing structured training for caregivers to ensure proper administration of the therapy. Data collected will help clarify the efficacy and safety of this treatment approach.

Why it matters

Potential benefit: If successful, this study could provide a more effective treatment option for children with intractable epilepsy.

How similar studies have gone: Previous studies have shown promising results with ketogenic therapy for epilepsy, indicating that this approach is both established and potentially effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients whose physician has prescribed the ketogenic diet
* Patients with lab tests consistent with the ability to metabolize a high fat and low carbohydrate diet
* Patients that can be compliant with administration of the therapy and with record keeping.

Exclusion Criteria:

* Patients with lab tests consistent with the inability to metabolize a high fat and low carbohydrate diet
* Patients at risk of being non-compliant with administration of the therapy and with record keeping

Where it's running

  • University of Florida
    Gainesville, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Peggy R. Borum, Ph.D. — University of Florida
  • Study coordinator: Peggy R. Borum, Ph.D.
  • Email: prb@ufl.edu
  • Phone: 352-562-2861

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease

    This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.

    Recruiting Phase 3 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Granada, Andalusia and 4 other locations · NCT07234695

  • Recognizing seizures in the intensive care unit

    This project tests how well NHS neurophysiology scientists, neurologists, intensivists, and ICU nurses can identify seizures from digital video recordings of ICU events.

    Recruiting Nottingham University Hospitals NHS Trust · Nottingham, Nottinghamshire · NCT07136298

  • Preventing first seizures with levetiracetam in patients with motor cortex brain metastases

    This test will try giving levetiracetam to adults with motor cortex brain metastases who have never had a seizure to see if it prevents a first seizure compared with not giving the drug.

    Recruiting Phase 2 Brigham and Women's Hospital · Boston, Massachusetts · NCT07130786

  • Preventing early seizures after traumatic brain injury

    This randomized study will test whether phenytoin, levetiracetam, or placebo best prevent early seizures in people hospitalized with moderate-to-severe traumatic brain injury.

    Recruiting at 3 sites Phase 4 All India Institute of Medical Sciences, Jodhpur · Chandigarh, Punjab and 2 other locations · NCT07072624

  • Wearable device for detecting seizures

    This study tests a new wearable device for detecting seizures in people with epilepsy to see if it works well and can help them feel more comfortable in their daily lives.

    Recruiting at 2 sites University of Massachusetts, Worcester · Worcester, Massachusetts and 1 other locations · NCT06598189

  • Registry for patients with thyroid hormone resistance

    This study is collecting information from patients with thyroid hormone resistance to see how their specific gene mutations affect their health and improve diagnosis and treatment.

    Recruiting Charite University, Berlin, Germany · Berlin · NCT06566066

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.